Teruaki Yuzuriha

Title: Teruaki Yuzuriha: Innovator in Tissue Plasminogen Activator Analog Research

Introduction

Teruaki Yuzuriha is a notable inventor based in Sakura, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of tissue plasminogen activator (t-PA) analogs. His work focuses on enhancing the specificity and efficacy of these analogs for therapeutic applications.

Latest Patents

Yuzuriha holds 2 patents that showcase his innovative approaches. His latest patents include "Tissue plasminogen activator analogs having modified growth factor," which describes t-PA analogs containing the growth factor domain of native t-PA. This domain has at least one cysteine residue replaced with another amino acid. The patent also discusses pharmaceutical compositions that incorporate these t-PA analogs along with a physiologically acceptable carrier or diluent. Another significant patent is "Modified t-PA with kringle replaced by another kringle," which presents t-PA analogs that exhibit greater specificity for fibrin than native t-PA. These analogs include the K1 domain of native t-PA replaced with another kringle domain, enhancing the binding of the analog to fibrin.

Career Highlights

Teruaki Yuzuriha is currently associated with Zymogenetics, Inc., where he continues to advance his research in the field of biotechnology. His work has been instrumental in developing new therapeutic strategies that leverage the unique properties of t-PA analogs.

Collaborations

Yuzuriha collaborates with esteemed colleagues, including Eileen R Mulvihill and Shinji Yoshitake. Their combined expertise contributes to the innovative research and development efforts at Zymogenetics, Inc.

Conclusion

Teruaki Yuzuriha's contributions to the field of tissue plasminogen activator analogs highlight his role as a leading inventor in biotechnology. His innovative patents and collaborations continue to pave the way for advancements in therapeutic applications.